Stopped: Difficulty recruiting cases due to the epidemic
Insomnia is the most common sleep disorder in patients with primary brain tumors. In the past, 21.5% to 59.2% of patients with primary brain tumors suffer from insomnia symptoms. In addition to hypnotics, nonpharmacological interventions for insomnia in patients with brain tumors are still lacking. When using hypnotics may cause daytime sleepiness, cognitive impairment, and increase the risk of cancer, seeking an effective intervention is of clinical importance. Sensorimotor rhythm neurofeedback therapy has been shown to improve insomnia in different populations. However, its effect on insomnia has not been explored in patients with brain tumors. We, therefore, aim to investigate the feasibility and effect of sensorimotor rhythm neurofeedback in improving insomnia in patients with benign brain tumors after surgery and to examine the correlation between the degree of insomnia improvement and quality of life changes after receiving sensorimotor rhythm neurofeedback.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Changes in Insomnia Severity
Timeframe: at baseline and the 10th week after Intervention finished
Changes in Sleep parameters from sleep logs: sleep onset latency(SOL)
Timeframe: at baseline and the 10th week after Intervention finished
Changes in Sleep parameters from sleep logs: after sleep onset(WASO)
Timeframe: at baseline and the 10th week after Intervention finished
Changes in Sleep parameters from sleep logs: total sleep time(TST)
Timeframe: at baseline and the 10th week after Intervention finished
Changes in Sleep parameters from sleep logs: sleep efficiency(SE)
Timeframe: at baseline and the 10th week after Intervention finished